Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beyaz in Mexican Women Seeking Contraception
NCT01902264Phase 3Completed
- Sponsor
- Bayer
- Start
- Aug 2013
- Primary completion
- Feb 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of ethinyl estradiol + drospirenone + levomefolate calcium in contraception, neural tube defects (NTDs), sponsored by Bayer. Started Aug 2013; status: completed.
02
Drugs
ethinyl estradiol + drospirenone + levomefolate calcium
03
Conditions
contraceptionneural tube defects (NTDs)
Beyond the preview
Go deeper on NCT01902264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01902264.